FDA inspection
Merck Sharp & Dohme: FDA inspection ending Dec 17, 1999
FDA inspection 8556 · No Action Indicated (NAI) · Paris
Key facts
| Inspection ID | 8556 |
|---|---|
| Firm | Merck Sharp & Dohme |
| FEI number | 1000360120 |
| Address | 3 Avenue Hoche, BP 134 |
| City | Paris |
| Fiscal year | 2000 |
| Inspection end date | Dec 17, 1999 |
| Classification | No Action Indicated (NAI) |
| Project area | Post Mrkt Surv & Epid: Human Drugs |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data